We are a leading global contract research and manufacturing organization providing customers fully integrated drug discovery, development, and manufacturing services. We supply a broad range of services and technologies supporting the discovery and development of pharmaceutical products, the manufacture of Active Pharmaceutical Ingredients (“API”) and fine chemicals, the development and manufacture of drug product (“DP”) for new and generic drugs, as well as research, development and manufacturing for the agrochemical and other industries. In addition, we offer analytical and testing services to the medical device and personal care industry. With locations in the United States, Europe, and Asia, we maintain geographic proximity to our customers and flexible cost models.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Icon • Syneos Health • Medpace • Incyte • Zymergen • OmniAb ...
SEC CIK
Corporate docs
IRS number
141742717
Latest filings (excl ownership)
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
EFFECT
Notice of effectiveness
22 Sep 17
15-12B
Securities registration termination
31 Aug 17
25-NSE
Exchange delisting
31 Aug 17
8-K
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR
31 Aug 17
Latest ownership filings
SC 13G/A
Albany Molecular Research Inc
14 Feb 18
SC 13G/A
Albany Molecular Research Inc
13 Feb 18
4
MILTON BOYER
5 Sep 17
4
KENNETH PAUL HAGEN
5 Sep 17
4
Steven R Hagen
5 Sep 17
4
LORI M. HENDERSON
5 Sep 17
4
ANTHONY J MADDALUNA
5 Sep 17
4
KEVIN OCONNOR
5 Sep 17
4
William S Marth
5 Sep 17
4
AMBRA THOMAS E D
5 Sep 17
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|